Botulinum Toxin A Injections for Arm Stiffness After Stroke
Tests botulinum toxin A injections in the elbow muscles of adults with chronic stroke.
Key facts
- Who runs it
- Centre Hospitalier Universitaire De Toulouse
- Where
- St Amand Les Eaux and Toulouse, FranceSee the 2 sites
- Registry title
- Upper-limb Active Function and Botulinum Toxin A
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 80 people, planned
- Started
- 18 Dec 2020
- Expected to end
- 18 Dec 2027
- Type of study
- Interventional
- Record updated
- 31 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a stroke more than 6 months ago and need botulinum toxin A injections in the elbow flexor muscles. A control group of adults without arm problems also takes part.
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Patient group: ischemic or hemorrhagic stroke more than 6 months ago. Active elbow extension of at least 20°, limited by at least 15° or done with a speed reduced by 50%.
- Earlier treatment
- Patient group: no earlier botulinum toxin A (TBA) injection, or more than 4 months since a first TBA injection in the elbow flexors. The doctor prescribes abobotulinumtoxinA (DYSPORT®).
Main reasons for not taking part
- Passive limitation of elbow extension of more than 30°
- Pain during active elbow bending or stretching
- Unstable epilepsy, or progressive or decompensated neurological disease
- Contraindication to botulinum toxin, such as myasthenia, swallowing disorders or skin infection at the injection site
- Pregnant or breastfeeding women
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Patient group: Ischemic or hemorrhagic stroke of more than 6 months, of cortical and/or subcortical location
- Control group: Age > 18 years
- Control group: Signing of informed consent
- Patient group: Indication for performing a TBA injection in the elbow flexor muscles according to the usual clinical criteria: presence of a functional or aesthetic complaint expressed by the patient, linked to muscular hyperactivity (spasticity or co-contraction) on the elbow flexor muscles, and requiring focal treatment by injection of botulinum toxin
- Patient group: Being prescribed the molecule abobotulinumtoxinA (DYSPORT®, Ipsen-Pharma)
- Patient group: Possibility of active elbow extension of at least 20°
- Patient group: Limitation of active elbow extension movement by at least 15° or performance of a complete movement with a speed reduced by 50%
- Patient group: TBA-naïve patients or more than 4 months after a first TBA injection, targeting the elbow flexors
- Patient group: Age > 18 years
- Patient group: Signing of informed consent
- Patient group: Patient affiliated to a social security scheme
Who cannot take part
- Patient group: Cognitive disorder limiting the understanding of three basic instructions (test type of the 3 MMS papers test)
- Patient group: Unstable epilepsy
- Patient group: Anticoagulant treatment at curative dose or haemostasis disorder (prolonged bleeding time) contraindicating intramuscular injections
- Patient group: General contraindication to the use of botulinum toxin: hypersensitivity to the active substance (toxin-haemagglutinin complex BoTX-A) or to one of the excipients (albumin solution), history of myasthenia, Lambert Eaton syndrome, history of neuromuscular disease, surgery with curarization for less than 1 month, treatment with aminoglycosides, aminoquinolines, cyclosporine or anticholinesterases, History or presence of swallowing disorders (choking on solids or liquids), History or presence of chronic respiratory disorders (known respiratory failure), presence of a skin infection or inflammation at the injection site
- Patient group: Passive limitation of elbow extension > 30°
- Patient group: Legal incapacity (judicial protection, curatorship, guardianship)
- Patient group: Pregnant or breastfeeding women
- Patient group: Women who want to become pregnant within 18 months
- Patient group: Premenopausal women (menopause being defined by an absence of menstruation for at least 12 months without medical intervention) not using one of the following methods of contraception considered to be very reliable: intrauterine device, estrogen-progestin or progestin contraception inhibiting ovulation delivered by an implanted subcutaneous device, or tubal ligation
- Control group: History or progressive orthopedic or neurological damage to the upper limbs
- Control group: Subject expert in a sport requiring intensive use of the upper limbs (competition, at least departmental level)
- Control group: Legal incapacity (judicial protection, curatorship, guardianship)
- Patient group: Pain when performing active elbow flexion/extension movements
- Patient group: Boston Diagnostic Severity Aphasia Examination score ≤3
- Patient group: Progressive or decompensated neurological pathology
- Patient group: Claustrophobia or metallic foreign bodies contraindicating the performance of an MRI
Where in France
- Centre Hospitalier De St Amand Les EauxSt Amand Les Eaux, FranceNot yet recruiting
- Centre Hospitalier Universitaire de ToulouseToulouse, FranceNot yet recruiting
About the trial
What the trial wants to find out
Evaluer l’effet d’injections de toxine botulique A dans les fléchisseurs du coude sur la réduction des cocontractions spastiques au cours d’un mouvement d’extension active de coude chez des patients hémiplégiques vasculaires chroniques.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Upper-limb Active Function and Botulinum Toxin A
- Plain-language title
- Botulinum Toxin A Injections for Arm Stiffness After StrokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 31 October 2024